Replimune Group, Inc. REPL

Set alert

Price alert · REPL

All alert types
17.61 USD +0.22 +1.27%

At close

17.61 0.00 0.00%

Pre-market · Nov 2, 4:21 AM ET

Bid
17.58 × 2
Ask
17.59 × 2
16.64 Day range 18.27
1.50 52-week range 18.27
YTD
+81.17%
1 year
+80.99%
Open
17.49
Prev close
17.39
Mkt cap
1.67B
Vol
3.85M
Avg vol
3.01M
EPS
-2.79
P/E
0.00
Div yield
0.00%
More statistics
Low
16.64
High
18.27
Forward P/E
-27.19
Beta
0.00
Short ratio
11.50
Inst. own
105.29%
Dividend
0.00
Ex-div date
Earnings
Feb 2, 2027
50-d avg
13.51
200-d avg
9.24
1y target
23.33

1D chart

Chart tools
Interval

Signals (92)
NameTimeAgo
SMA: Bullish3:59 PM2 days ago
SMA: Bullish3:57 PM2 days ago
SMA: Bearish3:56 PM2 days ago
MACD: Sell Signal3:55 PM2 days ago
MACD: Buy Signal3:49 PM2 days ago
SMA: Bullish3:45 PM2 days ago
SMA: Bearish3:44 PM2 days ago
SMA: Bearish3:39 PM2 days ago
MACD: Sell Signal3:39 PM2 days ago
MACD: Buy Signal3:33 PM2 days ago
SMA: Bullish3:32 PM2 days ago
SMA: Bearish3:31 PM2 days ago
MACD: Sell Signal3:31 PM2 days ago
MACD: Buy Signal3:24 PM2 days ago
MACD: Sell Signal3:19 PM2 days ago
RSI: Overbought3:13 PM2 days ago
RSI: Overbought3:10 PM2 days ago
SMA: Bullish3:08 PM2 days ago
MACD: Buy Signal3:08 PM2 days ago
SMA: Bullish3:04 PM2 days ago
SMA: Bullish3:04 PM2 days ago
MACD: Sell Signal3:02 PM2 days ago
SMA: Bullish2:56 PM2 days ago
SMA: Bullish2:56 PM2 days ago
MACD: Buy Signal2:56 PM2 days ago
SMA: Bearish2:55 PM2 days ago
MACD: Sell Signal2:55 PM2 days ago
MACD: Buy Signal2:53 PM2 days ago
MACD: Sell Signal2:52 PM2 days ago
SMA: Bullish2:43 PM2 days ago
SMA: Bearish2:42 PM2 days ago
SMA: Bullish2:40 PM2 days ago
MACD: Buy Signal2:35 PM2 days ago
RSI: Oversold2:24 PM2 days ago
SMA: Bearish2:20 PM2 days ago
SMA: Bearish2:19 PM2 days ago
MACD: Sell Signal1:59 PM2 days ago
SMA: Bullish1:43 PM2 days ago
SMA: Bullish1:43 PM2 days ago
MACD: Buy Signal1:43 PM2 days ago
SMA: Bearish1:40 PM2 days ago
SMA: Bearish1:40 PM2 days ago
SMA: Bullish1:39 PM2 days ago
SMA: Bearish1:38 PM2 days ago
MACD: Sell Signal1:36 PM2 days ago
MACD: Buy Signal1:33 PM2 days ago
MACD: Sell Signal1:29 PM2 days ago
SMA: Bullish1:24 PM2 days ago
SMA: Bullish1:24 PM2 days ago
SMA: Bearish1:23 PM2 days ago
SMA: Bearish1:23 PM2 days ago
SMA: Bearish1:03 PM2 days ago
SMA: Bearish1:03 PM2 days ago
SMA: Bullish1:02 PM2 days ago
SMA: Bullish1:02 PM2 days ago
MACD: Buy Signal1:02 PM2 days ago
SMA: Bearish12:50 PM2 days ago
MACD: Sell Signal12:40 PM2 days ago
RSI: Overbought12:29 PM2 days ago
RSI: Overbought12:19 PM2 days ago
SMA: Bullish12:08 PM2 days ago
SMA: Bullish12:08 PM2 days ago
MACD: Buy Signal12:08 PM2 days ago
SMA: Bearish12:07 PM2 days ago
SMA: Bearish12:07 PM2 days ago
SMA: Bullish12:04 PM2 days ago
SMA: Bullish12:04 PM2 days ago
MACD: Sell Signal12:02 PM2 days ago
SMA: Bearish12:01 PM2 days ago
SMA: Bearish12:01 PM2 days ago
SMA: Bearish11:55 AM2 days ago
SMA: Bullish11:50 AM2 days ago
MACD: Buy Signal11:50 AM2 days ago
SMA: Bullish11:49 AM2 days ago
MACD: Sell Signal11:42 AM2 days ago
SMA: Bearish11:41 AM2 days ago
SMA: Bearish11:41 AM2 days ago
MACD: Buy Signal11:39 AM2 days ago
SMA: Bearish11:37 AM2 days ago
SMA: Bearish11:37 AM2 days ago
SMA: Bullish11:36 AM2 days ago
SMA: Bearish11:32 AM2 days ago
SMA: Bearish11:19 AM2 days ago
MACD: Sell Signal11:08 AM2 days ago
RSI: Overbought10:52 AM2 days ago
SMA: Bullish10:44 AM2 days ago
SMA: Bullish10:42 AM2 days ago
SMA: Bearish10:41 AM2 days ago
SMA: Bullish10:40 AM2 days ago
RSI: Oversold10:17 AM2 days ago
MACD: Buy Signal10:13 AM2 days ago
RSI: Oversold10:02 AM2 days ago

Discussion (20)

Sign in to join the discussion

Mark REPL 2 months ago #1

IOVA is king.

Mark REPL 2 months ago #2

Sold and loaded the boat with IOVA shares. Good luck.

Mark REPL 3 months ago #3

Wow that was close 10000 shares sold.

Mark REPL 3 months ago #4

Sold the news leaked on Reddit.

Mark REPL 3 months ago #5

Volume is low.. not good..

Circular Reference REPL 4 months ago #6

However, if Dr. Richard Pazdur returns to lead the FDA, the impact on Iovance Biotherapeutics (IOVA) is expected to be highly favorable, particularly for its long-term oncology pipeline.

Circular Reference REPL 4 months ago #7

A potential return of Dr. Richard Pazdur to the FDA is widely seen as bad news for REPL because he is historically the primary reason their melanoma drug was rejected.

John REPL 5 months ago #8

$REPL @TILS KILLS CANCER ?? Today is Monday, dummy

John REPL 5 months ago #9

$REPL ?? Oh SHIT! ? Its gonna take off

John REPL 5 months ago #10

Today the Earnings Date for $REPL ???